What Happened?
Boston, MA-based Monte Rosa Therapeutics Promoted Sharon Townson as Chief Technology Officer
About the Company
Small molecule protein degraders are set to reshape the way by which diseases will be treated. Our rational approach in targeting disease-causing proteins for degradation will deliver pioneering therapies for cancer and beyond. Headquartered in Boston with additional laboratory facilities in Basel, Monte Rosa Therapeutics is a private company launched in 2020. Initially seeded by Versant Ventures and incubated at Ridgeline Discovery in Basel, and The Institute of Cancer Research in London, Monte Rosa has raised $32.5 million from Versant and New Enterprise Associates. Academic co-founders are Prof. Raj Chopra and Prof. Ian Collins of The Institute for Cancer Research, UK.
About the Person
Sharon Townson is Chief Technology Officer at Monte Rosa Therapeutics. Previously, Sharon held various senior IT leadership roles in the industry.
Info Source
News
Short Profile